"A doctor is a person who helps to heal. I hope to be there for you to help heal the body and mind to the best of my ability."

- Dr. Khairullah

Joined the SCSP Team: 1995

Certification
Dr. Khairullah is certified by the American Board of Internal Medicine and its subspecialty board of Nephrology

Education
Quresh graduated from Lokmanya Tilak Municioal Medical College at Bombay University in Bombay, India.  His Internal Medicine Residency was completed at Bon Secours Hospital in Grosse Pointe and his Nephrology Fellowship at the University of Iowa Hospitals and Clinics

More About Dr. Khairullah
He is an Assistant Clinical Professor at  Wayne State University.

Interests:

• Chronic Kidney Disease (CKD) Management
• Glomerulonephritides
• Dialysis
• Kidney Transplantation
  

Professional Affiliations:

• Member at Large, Beaumont Grosse Pointe Executive Committee
• American Society of Nephrology
• American College of Physicians
• International Society of Nephrology
• Gift of Life Michigan
• Renal Physicians Association

Video Features:

Part 1 | Part 2 | Part 3

Part 1 | Part 2 | Part 3 | Part 4

Hospitals:

• St. John Hospital and Medical Center
• St. John North Shores
• Select Specialty - Grosse Pointe
• William Beaumont - Grosse Pointe
• Triumph Hospital - Detroit

• Home Dialysis
• Captopril renal scintigraphy in renovascular hypertension

• Comparison of Vancomycin Versus Cefazolin as Initial Therapy for Peritonitis in Peritoneal Dialysis Patients
  
  [Download full text article in Adobe PDF format]
  Khairullah, Q., Provenzano, R., Ahmed, A., Tayeb, T., Balakrisnan, B., Comparison of Vancomycin Versus Cefazolin as Initial Therapy for Peritonitis in Peritoneal Dialysis Patients, In press, Perit Dial Int 2002; 22:339-344.
  
• Early Detection of Prostate Cancer in the ESRD Population
  
  [View article listing on pubMed.gov]
  Khairullah, Q.T., Pamatmat, S.D., Chatha, M., Provenzano, R., Telang, D., Temple, M., Early Detection of Prostate Cancer in the ESRD Population, Clinical Nephrology, Vol. 61, No. 5, May 2004.
  BACKGROUND: There are currently no prostate cancer screening guidelines specific to the end-stage renal disease (ESRD) population. With this in mind, we evaluated the clinical usefulness of digital rectal examination (DRE), serum total prostate-specific antigen (PSA), prostate-specific antigen density (PSAD) and transrectal ultrasound (TRUS) in predicting prostate cancer in men with ESRD.
• Captopril renal scintigraphy in renovascular hypertension
  
  by Quresh T. Khairullah,  Douglas L. Somers,  Recayi Aktay, American Family Physician,  May 1, 1997